BACKGROUND
Medullary thyroid cancer (MTC) is a rare type of thyroid cancer that starts in special cells called C‑cells. These cells make a hormone called calcitonin. Surgery is the main treatment for MTC. MTC can spread outside of the thyroid to nearby lymph nodes in the neck early in the disease. Doctors know that when MTC spreads to more lymph nodes, the cancer can be harder to treat. However, they have not been sure how many lymph nodes involved would place a patient at higher risk.

This study was done to find clear cutoff numbers— “thresholds”—that can help doctors understand how the number of cancer‑containing lymph nodes relates to a patient’s chances of the cancer coming back or affecting survival. The goal of this study was to identify specific numbers of lymph nodes that help predict patient outcomes in MTC.

THE FULL ARTICLE TITLE
Lindsay CV, et al. Prognostic thresholds for lymph node metastasis in medullary thyroid cancer: a restricted cubic splines analysis. Thyroid 2025;35(11):1297–1310.

SUMMARY OF THE STUDY
This study looked at over 2,000 people with MTC from a large national database (SEER Database). All patients had surgery to remove the thyroid and evaluate lymph nodes. The researchers checked how many lymph nodes contained cancer and calculated a “lymph node ratio,” which compares the number of cancer‑containing lymph nodes to the total number removed.

They found that patients with 8 or more cancer‑positive lymph nodes or a lymph node ratio of 14% or higher had worse outcomes. These findings were then double‑checked using information from another group of 149 patients, and the same patterns were seen.

Of note, patients who had spread of MTC to the lymph nodes were more often male, had larger cancer size and higher likelihood of cancer extension and spread to other areas of the body. Patients with MTC that stayed in the thyroid lived longer than patients where the MTC had spread to the lymph nodes.

WHAT ARE THE IMPLICATIONS OF THIS STUDY?
The study showed that certain numbers of cancer‑containing lymph nodes—8 or more—and a lymph node ratio of at least 14% can help predict which MTC patients are more likely to have the cancer return or have worse long‑term outcomes. This allows doctors to plan more aggressive surgery and closer follow up in these patients. For patients, this means doctors may be able to give clearer information about risk after surgery. These thresholds may also help guide follow‑up care, such as how often to check calcitonin levels, get imaging tests, or decide on additional treatment.

— Maria Brito, MD, ECNU

Table of Contents | PDF File for Saving and Printing